SNRPCP9

Across TCGA pan-cancer cohorts, SNRPCP9 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated SNRPCP9 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SNRPCP9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNRPCP9 expression acts as an unfavorable survival marker, although some lineages such as KIRP and LIHC show a favorable association.

UCEC, MESO, and KIRP are the cancer types where SNRPCP9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.398	0.742	<.001	144	view →
MESO	OS	Tertile	All	0.190	0.608	.002	69	view →
KIRP	DFS	Tertile	All	0.981	0.869	.002	33	view →
READ	DFS	Tertile	II,III,IV	0.535	0.852	.005	27	view →
LIHC	OS	Tertile	All	0.890	0.661	.003	27	view →
KIRC	DFS	Tertile	III,IV	0.863	0.677	.015	24	view →
SARC	OS	Tertile	All	0.946	0.780	.004	18	view →
THCA	OS	Quartile	All	0.869	0.970	.021	16	view →
ESCA	OS	Tertile	III,IV	0.657	0.348	.020	15	view →
TGCT	OS	Tertile	II,III,IV	0.802	1.000	.040	12	view →
BRCA	OS	Tertile	III,IV	0.963	0.878	.012	12	view →
SKCM	DFS	Tertile	II,III,IV	0.809	0.650	.019	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

SNRPCP9–UCEC (OS)

Open the UCEC breakdown →